Skip to main content

Table 4 Detailed clinical outcomes and costs, for participants of strategies on the cost-effectiveness frontier

From: Lung cancer screening by low-dose computed tomography: a cost-effectiveness analysis of alternative programmes in the UK using a newly developed natural history-based economic model

Screening programme strategy

No screening

S-60-75-3%

S-55-75-3%

S-55-80-3%

T-55-80-3%

Mean outcomes per participant (versus no screening)

 Number of screens

 

1.00

1.00

1.00

2.70

 Number of false positives

 

0.33

0.33

0.33

0.95

 Lead time (years)

 

0.2995

0.2992

0.2952

0.3946

 Life years gained (years)

 

0.0537

0.0568

0.0524

0.0762

 QALYs

 

0.0008

0.0009

0.001

0.0012

 Change in lung cancer mortality

 

− 0.80%

− 0.45%

− 0.43%

− 0.64%

 Change in 5-year lung cancer survival

 

+ 16.1%

+ 16.4%

+ 16.1%

+ 21.0%

 Change in survival with lung cancer (years)

 

+ 1.87

+ 1.89

+ 1.85

+ 2.44

 Change in age at lung cancer diagnosis (years)

 

− 1.7

− 1.69

− 1.62

− 2.03

 Change in age at death from any cause (years)

 

+ 0.05

+ 0.06

+ 0.05

+ 0.08

 Change in age at death from lung cancer (years)

 

+ 0.16

+ 0.2

+ 0.23

+ 0.41

Outcomes per 100,000 participants

 Proportion of diagnoses arising from screening

 

44.4%

44.3%

47.1%

62.5%

 Number of screen-detected cases

 

1710

1785

2335

3185

 Number of interval cancers

 

0

0

0

215

 Additional lung cancer diagnoses

 

295

300

450

590

 Lung cancer deaths averted

 

170

100

120

180

 Life years gained

 

5367

5677

5242

7617

Costs for each participant (£, versus no screening)

 LDCT screening

 

104

104

104

275

 Lung cancer care

 

1458

1445

1469

1724

 End-of-life

 

534

530

515

505

 Total

 

2097

2080

2088

2504

Population of 13 million smokers aged 55–80 years (lifetime costs, £ million)

 Screening administration

0

80.16

110.97

118.66

118.66

 LDCT screening

0

41.42

43.53

54.06

142.48

 Lung cancer care

9355

9540

9547

9610

9742

 End-of-life

4979

4972

4971

4970

4965

 Total

14,334

14,633

14,673

14,753

14,968

 Additional vs no screening

 

299.1

338.8

418.5

634.2

  1. LDCT low-dose computed tomography, QALY quality-adjusted life year, S single one-off screen design, T triple-screen design. Strategy nomenclature: X-XX-XX-X% = screening programme design type-minimum entry age-maximum entry age-minimum lung cancer risk threshold